Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Losartan for Emotional Processing in Adolescents
NCT06636812Phase 1Recruiting
- Sponsor
- University of Oxford
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anxiety disorders comparing Losartan with Placebo (2 arms). Primary endpoint: Fear Extinction. Started Mar 2024; status: recruiting.
02
Drugs
losartan
03
Conditions
anxiety disorders
Beyond the preview
Go deeper on NCT06636812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06636812.